최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Best practice & research. Clinical rheumatology, v.31 no.3, 2017년, pp.415 - 428
Bengtsson, Anders A. (Lund University, Skå) , Rönnblom, Lars (ne University Hospital, Department of Clinical Sciences Lund, Rheumatology, 22185 Lund, Sweden)
Abstract Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that affects many different organ systems, with excessive production of type I interferons (IFNs) and autoantibodies against nucleic acids as hallmarks. Activation of the type I IFN system in SLE is due to cont...
Trends Immunol Ronnblom 22 8 427 2001 10.1016/S1471-4906(01)01955-X An etiopathogenic role for the type I IFN system in SLE
Semin Immunol Ronnblom 23 2 113 2011 10.1016/j.smim.2011.01.009 The type I interferon system in the development of lupus
Autoimmun Rev Smith 10 1 43 2010 10.1016/j.autrev.2010.08.016 Systemic lupus erythematosus: clinical presentations
N. Engl J Med Tsokos 365 22 2110 2011 10.1056/NEJMra1100359 Systemic lupus erythematosus
Transl Res J Lab Clin Med Crow 165 2 296 2015 Targeting of type I interferon in systemic autoimmune diseases
Autoimmun Rev Yaniv 14 1 75 2015 10.1016/j.autrev.2014.10.003 A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients
N. Engl J Med Arbuckle 349 16 1526 2003 10.1056/NEJMoa021933 Development of autoantibodies before the clinical onset of systemic lupus erythematosus
Autoimmun Rev Agmon-Levin 11 8 593 2012 10.1016/j.autrev.2011.10.020 Systemic lupus erythematosus one disease or many?
J Exp Med Bennett 197 6 711 2003 10.1084/jem.20021553 Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
Curr Opin Rheumatol Crow 26 5 467 2014 10.1097/BOR.0000000000000087 Advances in understanding the role of type I interferons in systemic lupus erythematosus
Curr Opin Rheumatol Ronnblom 25 2 248 2013 10.1097/BOR.0b013e32835c7e32 The interferon signature in autoimmune diseases
Nature Bialas 546 7659 539 2017 10.1038/nature22821 Microglia-dependent synapse loss in type I interferon-mediated lupus
Trends Microbiol Gurtler 21 8 413 2013 10.1016/j.tim.2013.04.004 Innate immune detection of microbial nucleic acids
Nat Immunol Kawai 11 5 373 2010 10.1038/ni.1863 The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
EMBO J Rigby 33 6 542 2014 10.1002/embj.201386117 RNA: DNA hybrids are a novel molecular pattern sensed by TLR9
Biochimie Fitzgerald-Bocarsly 89 6-7 843 2007 10.1016/j.biochi.2007.04.018 The role of type I interferon production by dendritic cells in host defense
Nat Rev Immunol Swiecki 15 8 471 2015 10.1038/nri3865 The multifaceted biology of plasmacytoid dendritic cells
Science Liu 347 6227 aaa2630 2015 10.1126/science.aaa2630 Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
Annu Rev Immunol Wu 32 461 2014 10.1146/annurev-immunol-032713-120156 Innate immune sensing and signaling of cytosolic nucleic acids
J Immunol Bave 171 6 3296 2003 10.4049/jimmunol.171.6.3296 Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG
Arthritis Rheum Lovgren 54 6 1917 2006 10.1002/art.21893 Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA
Autoimmun Rev Pinegin 14 7 633 2015 10.1016/j.autrev.2015.03.002 Neutrophil extracellular traps and their role in the development of chronic inflammation and autoimmunity
Proc Natl Acad Sci U S A Hakkim 107 21 9813 2010 10.1073/pnas.0909927107 Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
Arthritis Res Ther Leffler 17 205 2015 10.1186/s13075-015-0726-y A subset of patients with systemic lupus erythematosus fails to degrade DNA from multiple clinically relevant sources
Sci Transl Med Garcia-Romo 3 73 73ra20 2011 10.1126/scitranslmed.3001201 Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus
J Exp Med Caielli 213 5 697 2016 10.1084/jem.20151876 Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus
Nat Med Lood 22 2 146 2016 10.1038/nm.4027 Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease
Arthritis Rheumatol Mavragani 68 11 2686 2016 10.1002/art.39795 Expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease
Annu Rev Immunol Schneider 32 513 2014 10.1146/annurev-immunol-032713-120231 Interferon-stimulated genes: a complex web of host defenses
Trends Immunol Hoffmann 36 3 124 2015 10.1016/j.it.2015.01.004 Interferons and viruses: an evolutionary arms race of molecular interactions
Nat Rev Immunol Platanias 5 5 375 2005 10.1038/nri1604 Mechanisms of type-I- and type-II-interferon-mediated signalling
Lupus Barbhaiya 23 6 588 2014 10.1177/0961203314530488 Ultraviolet radiation and systemic lupus erythematosus
Semin Immunopathol Kuhn 38 1 97 2016 10.1007/s00281-015-0550-0 Lupus erythematosus revisited
Nat Immunol Wack 16 8 802 2015 10.1038/ni.3212 Guarding the frontiers: the biology of type III interferons
J Invest Dermatol Zahn 131 1 133 2011 10.1038/jid.2010.244 Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNlambda) in cutaneous lupus erythematosus
J Biol Chem Kemp 290 19 12184 2015 10.1074/jbc.M115.649301 UV light potentiates STING (stimulator of interferon genes)-dependent innate immune signaling through deregulation of ULK1 (Unc51-like kinase 1)
Expert Opin Drug Saf Rubin 14 3 361 2015 10.1517/14740338.2015.995089 Drug-induced lupus
Nat Rev Mol Cell Biol Biggar 16 1 5 2015 10.1038/nrm3915 Non-histone protein methylation as a regulator of cellular signalling and function
Arthritis Rheum Deapen 35 3 311 1992 10.1002/art.1780350310 A revised estimate of twin concordance in systemic lupus erythematosus
Nat Genet Bentham 47 12 1457 2015 10.1038/ng.3434 Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus
J Autoimmun Cui 41 25 2013 10.1016/j.jaut.2013.01.008 Genetic susceptibility to SLE: recent progress from GWAS
Curr Opin Rheumatol Deng 26 5 482 2014 10.1097/BOR.0000000000000086 Advances in lupus genetics and epigenetics
Curr Opin Rheumatol Chen 29 5 423 2017 10.1097/BOR.0000000000000411 Genetic advances in systemic lupus erythematosus: an update
Curr Opin Immunol Bronson 24 5 530 2012 10.1016/j.coi.2012.07.008 The genetics of type I interferon in systemic lupus erythematosus
Arthritis Rheum Niewold 58 8 2481 2008 10.1002/art.23613 Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients
Hum Mol Genet Berggren 24 12 3571 2015 10.1093/hmg/ddv095 IFN-alpha production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases
PLoS One Bolin 8 12 e84450 2013 10.1371/journal.pone.0084450 Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis
Arthritis Rheum Crow 63 12 3661 2011 10.1002/art.30603 Lupus: how much “complexity” is really (just) genetic heterogeneity?
Hum Mol Genet Sigurdsson 17 18 2868 2008 10.1093/hmg/ddn184 A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5
Ann Rheum Dis Svenungsson 69 5 834 2010 10.1136/ard.2009.115535 A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus
Ann Rheum Dis Olsson 2017 10.1136/annrheumdis-2017-211287 A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus
Nat Genet Zhao 49 3 433 2017 10.1038/ng.3782 A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases
Proc Natl Acad Sci U S A Jacob 109 2 E59 2012 10.1073/pnas.1113251108 Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase
Antioxidants Redox Signal Kelkka 21 16 2231 2014 10.1089/ars.2013.5828 Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature
Curr Opin Immunol Elkon 24 6 665 2012 10.1016/j.coi.2012.08.004 Complement, interferon and lupus
Nat Genet Lee-Kirsch 39 9 1065 2007 10.1038/ng2091 Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus
Arthritis Rheum Lood 60 10 3081 2009 10.1002/art.24852 C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis
J Immunol Santer 185 8 4738 2010 10.4049/jimmunol.1001731 C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes
J Interferon Cytokine Res Offic J Int Soc Interferon Cytokine Res Hertzog 31 1 5 2011 10.1089/jir.2010.0126 Systems biology of interferon responses
Nat Rev Immunol Gonzalez-Navajas 12 2 125 2012 10.1038/nri3133 Immunomodulatory functions of type I interferons
Trends Immunol Schreiber 36 3 139 2015 10.1016/j.it.2015.01.002 The molecular basis for functional plasticity in type I interferon signaling
Nat Rev Immunol McNab 15 2 87 2015 10.1038/nri3787 Type I interferons in infectious disease
Trends Mol Med Grammatikos 18 2 101 2012 10.1016/j.molmed.2011.10.005 Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus
Arthritis Rheum Eloranta 65 4 853 2013 10.1002/art.37821 Disease mechanisms in rheumatology-tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases
Clin Dev Immunol Alunno 2012 823085 2012 10.1155/2012/823085 Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new
Curr Opin Immunol Jackson 33 70 2015 10.1016/j.coi.2015.01.018 B cells take the front seat: dysregulated B cell signals orchestrate loss of tolerance and autoantibody production
Sci Rep Lopez 6 20651 2016 10.1038/srep20651 A pathogenic IFNalpha, BLyS and IL-17 axis in systemic lupus erythematosus patients
Cytokine Vazquez 74 2 318 2015 10.1016/j.cyto.2015.02.007 B cells responses and cytokine production are regulated by their immune microenvironment
Arthritis Rheum Thacker 64 9 2975 2012 10.1002/art.34504 Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis
Curr Opin Rheumatol Knight 25 5 597 2013 10.1097/BOR.0b013e328363eba3 Cardiovascular disease in lupus: insights and updates
J Interferon Cytokine Res Official J Int Soc Interferon Cytokine Res Savan 34 5 318 2014 10.1089/jir.2013.0117 Post-transcriptional regulation of interferons and their signaling pathways
Immunol Rev Swiecki 234 1 142 2010 10.1111/j.0105-2896.2009.00881.x Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance
Arthritis Rheum Eloranta 60 8 2418 2009 10.1002/art.24686 Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells
Arthritis Rheum Berggren 64 10 3409 2012 10.1002/art.34599 B lymphocytes enhance interferon-alpha production by plasmacytoid dendritic cells
Ann Rheum Dis Leonard 75 9 1728 2016 10.1136/annrheumdis-2015-208055 Activated T cells enhance interferon-alpha production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes
J Immunol Hagberg 186 9 5085 2011 10.4049/jimmunol.1003349 IFN-alpha production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1beta and LFA-1
Life Sci Privratsky 87 3-4 69 2010 10.1016/j.lfs.2010.06.001 PECAM-1: conflicts of interest in inflammation
J Autoimmun Clement 56 23 2015 10.1016/j.jaut.2014.09.002 Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses in vitro and attenuates the development of experimental autoimmune arthritis in vivo
Sci Transl Med Duffau 2 47 47ra63 2010 10.1126/scitranslmed.3001001 Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus
Blood Lood 116 11 1951 2010 10.1182/blood-2010-03-274605 Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease
Clin Transl Immunol Oon 5 5 e79 2016 10.1038/cti.2016.26 Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway
Arthritis Rheumatol Furumoto 69 1 148 2017 10.1002/art.39818 Tofacitinib ameliorates murine lupus and its associated vascular dysfunction
Ann Rheum Dis Khamashta 75 11 1909 2016 10.1136/annrheumdis-2015-208562 Sifalimumab, an anti-interferon-alpha monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Ann Rheum Dis Kalunian 75 1 196 2016 10.1136/annrheumdis-2014-206090 A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE)
Arthritis Rheumatol Furie 69 2 376 2017 10.1002/art.39962 Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus
J Immunol Sun 190 6 2536 2013 10.4049/jimmunol.1202689 Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice
Arthritis Rheum Martin 68 Suppl 10 2016 BIIB059, an anti-BDCA2 monoclonal antibody, demonstrates acceptable safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects in a phase 1 study with single ascending doses (SAD) in healthy volunteers
EMBO Mol Med Pellerin 7 4 464 2015 10.15252/emmm.201404719 Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms
Arthritis Rheum Ichikawa 64 2 493 2012 10.1002/art.33333 Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells
Nat Immunol Volkman 15 5 415 2014 10.1038/ni.2872 The enemy within: endogenous retroelements and autoimmune disease
Arthritis Rheum Furie 63 12 3918 2011 10.1002/art.30613 A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Lancet Navarra 377 9767 721 2011 10.1016/S0140-6736(10)61354-2 Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Arthritis Res Ther Yao 12 Suppl 1 S6 2010 10.1186/ar2887 Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNalpha antibody, in systemic lupus erythematosus
Lupus Bengtsson 9 9 664 2000 10.1191/096120300674499064 Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
J Exp Med Rodero 214 5 1547 2017 10.1084/jem.20161451 Detection of interferon alpha protein reveals differential levels and cellular sources in disease
Proc Natl Acad Sci U S A Baechler 100 5 2610 2003 10.1073/pnas.0337679100 Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
Ann Rheum Dis Landolt-Marticorena 68 9 1440 2009 10.1136/ard.2008.093146 Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus
J Mol Med Strauss 95 7 753 2017 10.1007/s00109-017-1515-7 Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options
※ AI-Helper는 부적절한 답변을 할 수 있습니다.